{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Archexin",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "C194H228N70O103P19S19",
    "definition": "A 20-mer antisense oligodeoxynucleotide (ODN) against the proto-oncogene Akt with potential antineoplastic activity. Akt-1 antisense oligonucleotide RX-0201 binds to Akt-1 mRNA, inhibiting translation of the transcript; suppression of Akt-1 expression may result in the inhibition of cellular proliferation and the induction of apoptosis in tumor cells that overexpress Akt-1. Akt-1 is a serine-threonine protein kinase that stimulates proliferation and inhibits apoptosis of tumor cells.",
    "fdaUniiCode": "4TEW51C830",
    "identifier": "C88335",
    "preferredName": "Archexin",
    "semanticType": "Nucleic Acid, Nucleoside, or Nucleotide",
    "subclassOf": [
      "C1291"
    ],
    "synonyms": [
      "ARCHEXIN",
      "Akt-1 Antisense Oligonucleotide RX-0201",
      "Archexin",
      "RX-0201"
    ]
  }
}